Bespoke Extracts (BSPK) Change in Account Payables (2011 - 2022)

Bespoke Extracts (BSPK) reported Change in Account Payables of -$14648.0 for Q1 2022, down 152.17% sequentially from $28075.0 in Q4 2017.

Bespoke Extracts (BSPK) Change in Account Payables (2011 - 2022) Analysis & Trends

Bespoke Extracts (BSPK) has 8 years of Change in Account Payables data on file, last reported at -$14648.0 in Q1 2022.

For the quarter ending Q1 2022, Change in Account Payables changed N/A year-over-year to -$14648.0; the trailing twelve-month figure through Mar 2022 stood at $13967.0 (changed N/A YoY), and the FY2017 full-year result was -$14069.0, down 196.3% from the prior year.
Change in Account Payables fell to -$14648.0 in Q1 2022, from $28075.0 in the prior quarter.
In the past five years, Change in Account Payables ranged from a high of -$14648.0 in Q1 2022 to a low of -$14648.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Account Payables (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	62.00 Mn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	30.60 Mn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	32.70 Mn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Bespoke Extracts	1.12 Mn	1.11 Mn	234,175.00	-

Download Data